Rating History for Seelos Therapeutics (SEEL) by Roth Capital

Date Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/17/2021 Jonathan Aschoff Downgrade Neutral
(Buy)
4.00
(12.00)
5.19
(2.25)
-56.65% Details